Skip Navigation



JAC Advance Access published online on January 16, 2004

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh063
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/2/371    most recent
dkh063v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Levy, F.
Right arrow Articles by Walker, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, F.
Right arrow Articles by Walker, E. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 The British Society for Antimicrobial Chemotherapy

Original article

BRO {beta}-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis

F. Levy 1 * and E. S. Walker 2

1 Department of Biological Sciences, Box 70703, East Tennessee State University, Johnson City, TN 37614
2 Department of Internal Medicine, Box 70622, East Tennessee State University, Johnson City, TN 37614; James H. Quillen Veterans Affairs Medical Center (11C), Mountain Home, TN 37684, USA

* Corresponding author. E-mail: levyf{at}etsu.edu.

Received 18 July 2003 ; revised 7 November 2003 ; accepted 10 November 2003

Abstract

Objectives: The hypothesis that BRO-1 selectively replaced the BRO-2 isoform of the Moraxella catarrhalis BRO {beta}-lactamase was tested by examining the temporal distribution, antibiotic resistance and epidemiological characteristics of isolates from a long-term collection at a single locale.

Methods: A rapid, one-step PCR assay conducted on 354 isolates spanning 1984-1994 distinguished bro alleles in over 97% of the {beta}-lactamase-producing isolates. Probes of dot blots were used to distinguish PCR failure from non-{beta}-lactamase-mediated penicillin resistance.

Results: BRO-2 isolates comprised 0-10% of the population per year with no evidence of a decline over time. All {beta}-lactamase producers exceeded the clinical threshold for penicillin resistance. Bimodality of penicillin MICs for {beta}-lactamase producers was caused by variation within BRO-1 rather than differences between BRO-1 and BRO-2. Non-{beta}-lactamase factors also confer resistance to penicillin and may contribute to the BRO-1 bimodality. The 13 BRO-2 isolates were associated with diverse genotypes within which there was evidence of epidemiologically linked clusters. The exclusive association of BRO-2 with four unrelated genotypes suggested maintenance of BRO-2 by recurrent mutation or horizontal exchange.

Conclusions: The relative rarity of BRO-2 throughout the study, the absence of a declining temporal trend, and genetic diversity within BRO-2 all failed to support the hypothesis that BRO-2 was more common in the past and has been selectively replaced by BRO-1.

Keywords: disease transmission, molecular epidemiology, selection
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
M. A. Khan, J. B. Northwood, F. Levy, S. J. C. Verhaegh, D. J. Farrell, A. Van Belkum, and J. P. Hays
bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults
J. Antimicrob. Chemother., November 4, 2009; (2009) dkp401v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L. M. Deshpande, H. S. Sader, T. R. Fritsche, and R. N. Jones
Contemporary Prevalence of BRO {beta}-Lactamases in Moraxella catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004).
J. Clin. Microbiol., October 1, 2006; 44(10): 3775 - 3777.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.